HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-JUN-13 4L7O TITLE HUMAN ARTD3 (PARP3) - CATALYTIC DOMAIN IN COMPLEX WITH INHIBITOR TITLE 2 STO1542 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC PARP DOMAIN; COMPND 5 SYNONYM: PARP-3, HPARP-3, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN- COMPND 6 LIKE 3, ARTD3, IRT1, NAD(+) ADP-RIBOSYLTRANSFERASE 3, ADPRT-3, COMPND 7 POLY[ADP-RIBOSE] SYNTHASE 3, PADPRT-3; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADPRT3, ADPRTL3, PARP3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA4 KEYWDS DIPHTHERIA TOXIN LIKE ADP-RIBOSE TRANSFERASE, TRANSFERASE, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,A.E.G.LINDGREN,T.EKBLAD,S.SPJUT, AUTHOR 2 C.D.ANDERSSON,J.WEIGELT,A.LINUSSON,M.ELOFSSON,H.SCHULER REVDAT 2 20-SEP-23 4L7O 1 REMARK SEQADV REVDAT 1 19-FEB-14 4L7O 0 JRNL AUTH A.E.LINDGREN,T.KARLBERG,T.EKBLAD,S.SPJUT,A.G.THORSELL, JRNL AUTH 2 C.D.ANDERSSON,T.T.NHAN,V.HELLSTEN,J.WEIGELT,A.LINUSSON, JRNL AUTH 3 H.SCHULER,M.ELOFSSON JRNL TITL CHEMICAL PROBES TO STUDY ADP-RIBOSYLATION: SYNTHESIS AND JRNL TITL 2 BIOCHEMICAL EVALUATION OF INHIBITORS OF THE HUMAN JRNL TITL 3 ADP-RIBOSYLTRANSFERASE ARTD3/PARP3. JRNL REF J.MED.CHEM. V. 56 9556 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24188023 JRNL DOI 10.1021/JM401394U REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1095 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1515 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2755 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.20000 REMARK 3 B22 (A**2) : -0.94000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.20000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.188 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.111 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.600 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2851 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1930 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3861 ; 1.677 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4745 ; 0.980 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 352 ; 6.318 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 127 ;40.713 ;25.276 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 492 ;14.364 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;18.257 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 422 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3156 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 521 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1768 ; 1.036 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 709 ; 0.263 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2851 ; 1.876 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1083 ; 2.784 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1010 ; 4.556 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 176 A 532 REMARK 3 ORIGIN FOR THE GROUP (A): 18.5400 0.5750 11.9020 REMARK 3 T TENSOR REMARK 3 T11: 0.0181 T22: 0.0111 REMARK 3 T33: 0.0081 T12: 0.0019 REMARK 3 T13: 0.0081 T23: 0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.1308 L22: 0.2728 REMARK 3 L33: 0.1131 L12: -0.0092 REMARK 3 L13: -0.0201 L23: 0.0188 REMARK 3 S TENSOR REMARK 3 S11: -0.0083 S12: -0.0091 S13: -0.0114 REMARK 3 S21: -0.0546 S22: 0.0010 S23: -0.0207 REMARK 3 S31: -0.0199 S32: 0.0009 S33: 0.0072 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4L7O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1000080284. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21888 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : 0.12200 REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.67400 REMARK 200 R SYM FOR SHELL (I) : 0.47500 REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4GV4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M DL-MALIC ACID, 0.1M BIS-TRIS REMARK 280 -PROPANE , PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.45900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMERIC REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 242 REMARK 465 PRO A 243 REMARK 465 THR A 244 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 245 CG OD1 OD2 REMARK 470 GLU A 251 CD OE1 OE2 REMARK 470 ARG A 351 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 375 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 478 108.50 -51.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1VD A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L6Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1168. REMARK 900 RELATED ID: 4L70 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0352. REMARK 900 RELATED ID: 4L7L RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ME0368. REMARK 900 RELATED ID: 4L7N RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH STO1541. REMARK 900 RELATED ID: 4L7P RELATED DB: PDB REMARK 900 RELATED ID: 4L7R RELATED DB: PDB REMARK 900 RELATED ID: 4L7U RELATED DB: PDB DBREF 4L7O A 178 532 UNP Q9Y6F1 PARP3_HUMAN 178 532 SEQADV 4L7O SER A 176 UNP Q9Y6F1 EXPRESSION TAG SEQADV 4L7O MET A 177 UNP Q9Y6F1 EXPRESSION TAG SEQRES 1 A 357 SER MET LYS ARG VAL GLN PRO CYS SER LEU ASP PRO ALA SEQRES 2 A 357 THR GLN LYS LEU ILE THR ASN ILE PHE SER LYS GLU MET SEQRES 3 A 357 PHE LYS ASN THR MET ALA LEU MET ASP LEU ASP VAL LYS SEQRES 4 A 357 LYS MET PRO LEU GLY LYS LEU SER LYS GLN GLN ILE ALA SEQRES 5 A 357 ARG GLY PHE GLU ALA LEU GLU ALA LEU GLU GLU ALA LEU SEQRES 6 A 357 LYS GLY PRO THR ASP GLY GLY GLN SER LEU GLU GLU LEU SEQRES 7 A 357 SER SER HIS PHE TYR THR VAL ILE PRO HIS ASN PHE GLY SEQRES 8 A 357 HIS SER GLN PRO PRO PRO ILE ASN SER PRO GLU LEU LEU SEQRES 9 A 357 GLN ALA LYS LYS ASP MET LEU LEU VAL LEU ALA ASP ILE SEQRES 10 A 357 GLU LEU ALA GLN ALA LEU GLN ALA VAL SER GLU GLN GLU SEQRES 11 A 357 LYS THR VAL GLU GLU VAL PRO HIS PRO LEU ASP ARG ASP SEQRES 12 A 357 TYR GLN LEU LEU LYS CYS GLN LEU GLN LEU LEU ASP SER SEQRES 13 A 357 GLY ALA PRO GLU TYR LYS VAL ILE GLN THR TYR LEU GLU SEQRES 14 A 357 GLN THR GLY SER ASN HIS ARG CYS PRO THR LEU GLN HIS SEQRES 15 A 357 ILE TRP LYS VAL ASN GLN GLU GLY GLU GLU ASP ARG PHE SEQRES 16 A 357 GLN ALA HIS SER LYS LEU GLY ASN ARG LYS LEU LEU TRP SEQRES 17 A 357 HIS GLY THR ASN MET ALA VAL VAL ALA ALA ILE LEU THR SEQRES 18 A 357 SER GLY LEU ARG ILE MET PRO HIS SER GLY GLY ARG VAL SEQRES 19 A 357 GLY LYS GLY ILE TYR PHE ALA SER GLU ASN SER LYS SER SEQRES 20 A 357 ALA GLY TYR VAL ILE GLY MET LYS CYS GLY ALA HIS HIS SEQRES 21 A 357 VAL GLY TYR MET PHE LEU GLY GLU VAL ALA LEU GLY ARG SEQRES 22 A 357 GLU HIS HIS ILE ASN THR ASP ASN PRO SER LEU LYS SER SEQRES 23 A 357 PRO PRO PRO GLY PHE ASP SER VAL ILE ALA ARG GLY HIS SEQRES 24 A 357 THR GLU PRO ASP PRO THR GLN ASP THR GLU LEU GLU LEU SEQRES 25 A 357 ASP GLY GLN GLN VAL VAL VAL PRO GLN GLY GLN PRO VAL SEQRES 26 A 357 PRO CYS PRO GLU PHE SER SER SER THR PHE SER GLN SER SEQRES 27 A 357 GLU TYR LEU ILE TYR GLN GLU SER GLN CYS ARG LEU ARG SEQRES 28 A 357 TYR LEU LEU GLU VAL HIS HET 1VD A 601 29 HET DMS A 602 4 HETNAM 1VD N-{(1S)-1-[4-(1H-IMIDAZOL-1-YL)PHENYL]ETHYL}-3-(4-OXO- HETNAM 2 1VD 3,4-DIHYDROQUINAZOLIN-2-YL)PROPANAMIDE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 1VD C22 H21 N5 O2 FORMUL 3 DMS C2 H6 O S FORMUL 4 HOH *135(H2 O) HELIX 1 1 ASP A 186 PHE A 197 1 12 HELIX 2 2 SER A 198 MET A 209 1 12 HELIX 3 3 PRO A 217 LEU A 221 5 5 HELIX 4 4 SER A 222 LYS A 241 1 20 HELIX 5 5 SER A 249 ILE A 261 1 13 HELIX 6 6 SER A 275 GLN A 299 1 25 HELIX 7 7 SER A 302 VAL A 308 1 7 HELIX 8 8 HIS A 313 LEU A 322 1 10 HELIX 9 9 GLU A 335 GLY A 347 1 13 HELIX 10 10 GLU A 366 HIS A 373 1 8 HELIX 11 11 SER A 374 LEU A 376 5 3 HELIX 12 12 ASN A 387 ALA A 389 5 3 HELIX 13 13 VAL A 390 GLY A 398 1 9 HELIX 14 14 GLU A 418 GLY A 424 1 7 HELIX 15 15 PRO A 479 ASP A 482 5 4 HELIX 16 16 PRO A 503 SER A 506 5 4 HELIX 17 17 GLN A 519 SER A 521 5 3 SHEET 1 A 2 ARG A 179 VAL A 180 0 SHEET 2 A 2 GLU A 310 VAL A 311 1 O VAL A 311 N ARG A 179 SHEET 1 B 5 GLN A 325 LEU A 328 0 SHEET 2 B 5 THR A 354 ASN A 362 -1 O LYS A 360 N GLN A 327 SHEET 3 B 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 B 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 B 5 ARG A 379 GLY A 385 -1 N HIS A 384 O PHE A 440 SHEET 1 C 5 GLN A 325 LEU A 328 0 SHEET 2 C 5 THR A 354 ASN A 362 -1 O LYS A 360 N GLN A 327 SHEET 3 C 5 CYS A 523 HIS A 532 -1 O LEU A 528 N TRP A 359 SHEET 4 C 5 HIS A 434 ALA A 445 -1 N GLU A 443 O ARG A 524 SHEET 5 C 5 MET A 429 CYS A 431 -1 N CYS A 431 O HIS A 434 SHEET 1 D 4 ILE A 413 PHE A 415 0 SHEET 2 D 4 GLU A 514 ILE A 517 -1 O ILE A 517 N ILE A 413 SHEET 3 D 4 SER A 468 ALA A 471 -1 N VAL A 469 O LEU A 516 SHEET 4 D 4 GLU A 449 ILE A 452 1 N HIS A 450 O ILE A 470 SHEET 1 E 2 THR A 475 PRO A 477 0 SHEET 2 E 2 PRO A 499 PRO A 501 -1 O VAL A 500 N GLU A 476 SHEET 1 F 2 THR A 483 LEU A 487 0 SHEET 2 F 2 GLN A 490 VAL A 494 -1 O VAL A 494 N THR A 483 SITE 1 AC1 13 ASP A 284 LEU A 287 ASP A 291 HIS A 384 SITE 2 AC1 13 GLY A 385 THR A 386 ARG A 400 MET A 402 SITE 3 AC1 13 TYR A 414 SER A 422 TYR A 425 GLU A 514 SITE 4 AC1 13 DMS A 602 SITE 1 AC2 4 GLY A 398 LEU A 399 ARG A 400 1VD A 601 CRYST1 54.519 56.918 56.840 90.00 112.43 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018342 0.000000 0.007572 0.00000 SCALE2 0.000000 0.017569 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019034 0.00000